2010³â
1¿ù 15ÀÏ ¿ÀÈÄ
5½Ã~ 8 ½Ã,
1¿ù 16ÀÏ ¿ÀÀü 9½Ã~11
½Ã»çÀÌ¿¡ 2010³âµµ ½ÉÀåÆǸ·¿¬±¸ workshopÀ» ÀÎõ½Ã ¿ËÁø±º ¿µÈï¸é ¼±À縮 14-1 ( ¿À¼Çºô
ÆÒ¼Ç ) ¿¡¼
°³ÃÖÇÏ¿´´Ù.
¹ßÇ¥³»¿ëÀº; 1¿ù15ÀÏ
17;00 ±è¿ëÁø : Overview for cardiovascular xenograft.
17;25 ¹Ú¼º½Ä : Xenoreactive antigen removal (¥á-Gal) with
¥á-galactosidase
17;40 Á¶Àº¾Ö : Biomechanical change by fixation : crosslingking
characteristics
17;55 ÃÖ¼±¿µ
: Immunological Evaluation for xenograft : Development of recombinant
¥á-
galactosidase
and xenoreactive antigen removal with ¥á-galactosidase
18;10 ÀÌ Ã¶ : The effect of anticalcification using ¥á-Gal
knock out mouse model 1
18;25 ÀÓÈ«±¹ : The effect of anticalcification using ¥á-Gal
knock out mouse model 2
18;40 ¹Úõ¼ö : Evaluation of change in anti ¥á-Gal and
anti non-Gal antibody in human
serum for bioprosthetic heart valve
implantation
18;55 ±è¼öȯ : Geometry & design of heart valves : aortic & pulmonic
valves
19;10 ¿À»ï¼¼ : The design of bioprosthetic heart valve, porcine & pericardial
valve
19;25 ÀÌâÇÏ : The design of valved
conduit
19;40 È«°¼± : Manufacture & evaluation of implantable valve with stent
materials and percutaneous implantable stented
valve
1¿ù16ÀÏ¿¡´Â
9;00
Àå¿ì¼º ; Studies of mechanical
test ;
effects of tensile strength and elasticity
9;15
ÃÖâÈÞ : Studies on valve
fixation pressure : transvalvular & distension
pressure
9;30
¾çÁöÇõ : Large animal
experiment for xenograft implantation (pulmonary valved conduit with heparin
detoxification & decellularized pericardial
conduit).
9;45
ÀÌ¿µ¿Á : Effect of
anticalcification treatment with tissue preservation and fixation : in vivo
study using small animal subcutaneous
implantation
10;00
ÀåÇü¿ì
: Effect of anticalcification treatment with various tissue preservation and
fixation : in vivo study using small animal subcutaneous
implantation
10;15
Á¶¼º±Ô
: Effect of anticalcification treatment with various tissue preservation and
fixation : in vivo study using small animal subcutaneous
implantation
10;30
À¯Àç¼® : Study on Genipin : An alternative natural crosslinking agent for
heterograft
¿Í°°ÀÌ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ¿´À¸¸ç ¸¹Àº ÅäÀÇ°¡ ÀÖ¾ú´Ù.
±Ý¹ø ÀÌ workshopÀº ¸ðµç Âü¼®ÀÚ¿¡°Ô À¯ÀÍÇÏ°í ¼ºÈ²¸®
ÁøÇàµÇ¾ú´Ù.